IDOX PLC

Share Issue/Capital Change • Aug 1, 2022

National Storage Mechanism | Additional information

RNS Number : 3388U

IDOX PLC

01 August 2022

Idox plc

('Idox' or the 'Group' or the 'Company')

Exercise of Share Options &

Total Voting Rights

Idox plc (AIM: IDOX) a leading supplier of specialist information management software and solutions to the public and asset-intensive sectors, announces that it has issued 408,859 new Ordinary shares of 1 pence each in the Company ("Ordinary Shares") pursuant to an exercise of options by employees under its Idox plc Long Term Incentive Plans.

Applications have been made for the 408,859 new Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 8.00 a.m. on or around 2 August 2022.

The total number of Ordinary Shares in issue following Admission will be 452,270,295. The Company holds 1,426,219 Ordinary Shares in treasury. Therefore the total number of Ordinary Shares with voting rights in the Company will be 450,844,076.

The above figure of 450,844,076 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

-Ends-

Enquiries:

Idox plc	+44 (0) 870 333 7101
Chris Stone, Non-Executive Chairman David Meaden, Chief Executive Anoop Kang, Chief Financial Officer
Peel Hunt LLP (NOMAD and Broker)	+44 (0) 20 7418 8900
Edward Knight Paul Gillam James Smith
MHP Communications	+ 44 (0) 203 128 8100
Reg Hoare Matthew Taylor	idox@mhpc.com

About Idox plc

For more information see www.idoxplc.com @Idoxgroup

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TVRDZGZNVLDGZZM